diisopropylformamide, phosphorus oxychloride, piperidine and
diisopropylethylamine using procedure 1.1 and hexafluoro-
phosphate anion exchange as described in the General notes.
Salt 6ؒPF6 was recrystallised from hot acetone–chloroform to
afford colourless needles (62%); mp 209–210 ЊC; δH(400 MHz;
CDCl3) 1.38 (12 H, d, J 7, 4 × CH3), 1.76 (6 H, br m, 3 × CH2),
3.69 (4 H, m, 2 × CH2), 4.02 (2 H, br m, 2 × CH) and 8.15 (1 H,
s, NCHN); δC(100 MHz; CDCl3) 22.3 (br), 22.9, 25.9, 50.5, 54.5
and 152.8.
dried with anhydrous magnesium sulfate. Most of the solvent
was removed in vacuo and then the crude product was separated
as an orange oil by the addition of diethyl ether and n-pentane.
The oil was dissolved in water and filtered. The filtrate was
concentrated to afford 9ؒOTf as a colourless solid (16%); mp
165–170 ЊC. [α]2D0 Ϫ24.5 (Found: C, 51.9; H, 8.8; N, 6.6; S, 7.5.
C19H37F3N2O3S requires C, 53.0; H, 8.7; N, 6.5; S, 7.45%)
(NMR spectra were run at elevated temperatures to simplify
interpretation) δH(300 MHz; DMSO, 60 ЊC) 0.80–1.30 (5 H, br
m, 2 × CH2 and 1 × CH), 1.30–1.39 (21 H, 7 × CH3), 1.50–1.78
(6 H, br m, 3 × CH2), 3.53 (1 H, br dq, J 7, 1 × CH), 4.09 (3 H,
br septet, J 7, 3 × CH) and 7.48 (1 H, s, NCHN); δC(75.5 MHz;
DMSO, 60 ЊC) 20.33, 21.0 (br), 25.40, 25.47, 29.05, 30.09, 53.6
and 152.32; m/z (FAB) 281 (Mϩ, 100%).
Diisopropyl(piperidin-1-ylmethylidene)ammonium
salt
6ؒPF6 was also prepared from formylpiperidine, lithium diiso-
propylamide (prepared in diethyl ether from diisopropylamine
and n-BuLi) and triflic anhydride using procedure 2 and hexa-
fluorophosphate anion exchange as described in the General
notes. Physical and spectroscopic details were identical to the
sample prepared above (52%). Crystals of sufficient quality for
single crystal X-ray diffraction studies (Table 3) were obtained
by diffusion of diethyl ether into an acetone solution of 6ؒPF6.
(R)-(Ϫ)-{[(1-Cyclohexylethyl)isopropylamino]methylidene}-
diisopropylammonium tetrafluoroborate 9ؒBF4. Formamidinium
salt 9ؒBF4 was prepared from N-isopropyl-N-(R)-(Ϫ)-1-cyclo-
hexylethylformamide, phosphorus oxychloride and diiso-
propylamine by procedure 1.1 as described above. After the
reaction was complete, dichloromethane was added and the
reaction mixture was washed with sodium hydroxide solution
(2.0 M) and saturated sodium tetrafluoroborate solution. The
aqueous washings were extracted with dichloromethane and
the combined organic fractions were dried over anhydrous
magnesium sulfate and filtered. Most of the solvent was
removed in vacuo before the crude product was precipitated as
an orange oil by the addition of n-pentane. The product was
purified by column chromatography (10 : 1, CH2Cl2–MeOH),
to yield a tacky yellow oil. After removing traces of solvent,
repeated heating, cooling and removal of solid allowed
isolation. This procedure yielded the salt 9ؒBF4 as a pale yellow
solid (59%). Spectroscopic details were in agreement with those
of 9ؒOTf as prepared above.
(S)-(؉)-Diisopropyl(2-methoxymethylpyrrolidin-1-ylmethyl-
idene)ammonium tetrafluoroborate, 7ؒBF4. Formamidinium
salt 7ؒBF4 was prepared from (S)-(Ϫ)-1-formyl-2-(methoxy-
methyl)pyrrolidine, phosphorus oxychloride and diisopropyl-
amine using procedure 1.1. Dichloromethane was added to
the reaction mixture and the solution was re-cooled in ice and
washed with aqueous sodium hydroxide (2.0 M) and a saturated
aqueous solution of sodium tetrafluoroborate. The aqueous
washings were extracted with dichloromethane before being
dried over anhydrous magnesium sulfate, filtered and the
solvent removed in vacuo. The crude product, an orange oil,
was then purified by column chromatography (10 : 1, CH2Cl2–
MeOH). After removing traces of solvent, heating and cooling
of the resultant oil allowed crystallisation of salt 7ؒBF4 as a low
melting solid (77%); mp 50–51 ЊC; [α]2D0 ϩ108.7 (Found: C, 49.7;
H, 8.8; N, 9.3. C13H27BF4N2O requires C, 49.65; H, 8.7; N,
8.9%); δH(300 MHz; CDCl3) 1.36 (6 H, d, J 7, 2 × CH3), 1.38
(6 H, d, J 7, 2 × CH3), 1.65 (1 H, m, ring CH), 2.15 (3 H, m, ring
CH ϩ CH2), 3.37 (3 H, s, OCH3), 3.41–3.54 (2 H, m, CH2O),
3.82 (1 H, septet, J 7, CH), 3.90, 3.82–3.84 (2 H, m, CH2), 4.25
(1 H, m, CH), 4.62 (1 H, septet, J 7, CH) and 7.75 (1 H, s,
NCHN); δC(75.5 MHz; CDCl3) 24.4, 22.5, 20.6, 20.3, 25.7, 25.0,
49.0, 50.6, 58.6, 65.3, 74.1 and 151.4. m/z (EI) 227 (Mϩ, 55%).
Benzylidenediisopropylammonium chloride 10ؒCl. Iminium
salt 10ؒCl was prepared from N,N-diisopropylformamide,
phenyllithium and oxalyl chloride in diethyl ether using pro-
cedure 2 as described above. The easily hydrolysed solid product
was isolated by filtration under N2 and washed with Et2O
(37%); mp 225–230 ЊC (decomp.); δH(400 MHz; CD3OD) 1.58
(6 H, d, J 7, 2 × CH3), 1.64 (6 H, d, J 7, 2 × CH3), 4.63 (1 H,
septet, J 7, CH), 5.14 (1 H, septet, J 7, CH), 7.70–7.90 (5 H, m,
5 × ArH) and 9.18 (1 H, s, NCHN); δC(75 MHz; CD3OD) 20.6,
24.7, 56.9, 59.1, 129.0, 131.1, 133.0, 136.6 and 173.1.
N,NЈ-Dicyclohexyl-N,NЈ-diethylformamidinium
trifluoro-
methanesulfonate, 8ؒOTf. Salt 8ؒOTf was prepared from
N-cyclohexyl-N-ethylformamide, triflic anhydride and N-
cyclohexyl-N-ethylamine using procedure 1.2. The solution
was stirred at room temperature for 1 h before being poured
into diethyl ether giving a yellow oil. The oil was partitioned
between diethyl ether and water, with the ethereal fraction being
dried over anhydrous magnesium sulfate before filtration and
removal of the solvent in vacuo. The residue was recrystallised
from ethyl acetate and ether (85%) as fine colourless flakes;
mp 65–66 ЊC (Found: C, 52.6; H, 8.3; N, 6.8. C18H33F3N2O3S
requires C, 52.2; H, 8.0; N, 6.8%); δH(300 MHz; CDCl3) 1.26
(6 H, br t, J 7, 2 × CH3), 1.03–1.98 (20 H, br m, 10 × CH2), 3.48
(4 H, br q, J 7, 2 × CH2), 3.66 (2 H, br s, 2 × CH) and 7.94 (1 H,
br s, NCHN); δC(75 MHz; CDCl3) 15.6, 24.7, 25.2, 31.8, 41.0,
68.1, 122.9 (q, J 321) and 153.7; m/z (FAB) 265 (Mϩ, 100%), 236
(3), 213 (5), 182 (3) and 138 (6).
1,3-Diisopropyl-3,4,5,6-tetrahydropyrimidin-1-ium tetrafluoro-
borate, 11ؒBF4. Salt 11ؒBF4 was prepared from N,N Ј-diiso-
propylpropane-1,3-diamine, ammonium tetrafluoroborate and
triethyl orthoformate using procedure 3.1. The product mixture
was dissolved in acetonitrile and the insoluble ammonium
salt was removed by filtration. The acetonitrile was removed
under vacuum and the residue recrystallised by evaporation of
acetone (ca. 5–10%) from hot ethyl acetate to give fine colour-
less needles (83%); mp 144–145 ЊC (Found: C, 47.2; H, 8.4; N,
10.8. C10H21BF4N2 requires C, 46.9; H, 8.3; N, 10.9%); δH(400
MHz; (CD3)2CO) 1.34 (12 H, d, J 7, 4 × CH3), 2.14 (2 H, quin,
J 6, CH2), 3.51 (4 H, t, J 6, 2 × CH2), 4.01 (2 H, septet, J 7,
2 × CH) and 8.27 (1 H, s, NCHN); δC(100 MHz; (CD3)2CO)
19.8, 20.1, 39.7, 57.4 and 151.7; m/z (FAB) 169 (Mϩ, 100%) and
126 (3).¶
(R)-(Ϫ)-{[(1-Cyclohexylethyl)isopropylamino]methylidene}-
diisopropylammonium trifluoromethanesulfonate 9ؒOTf. Form-
amidinium salt 9ؒOTf was prepared from N-isopropyl-N-
(R)-(Ϫ)-1-cyclohexylethylformamide, triflic anhydride and
diisopropylamine by procedure 1.2 as described above. Once
the reaction was complete, dichloromethane was added and the
reaction mixture was washed with sodium hydroxide solution
(2.0 M) and distilled water. The aqueous layer was extracted
with dichloromethane and the combined organic washings
Formamidinium salt 11ؒBF4 was also prepared by reaction of
N,N Ј-diisopropylpropane-1,3-diamine with freshly prepared
oxonium salt 26ؒBF4 using procedure 3.2. The resulting precipi-
tate was recrystallised using the method above to give the
formamidinium salt 11ؒBF4 (59%) as fine colourless needles.
Spectroscopic details were in agreement with the product
isolated above.
¶ Single crystal X-ray structure previously reported.15
J. Chem. Soc., Perkin Trans. 1, 2001, 1586–1593
1591